High-resolution antibody dynamics following influenza vaccination reveal predominantly weak responses as well as infrequent but durable immunity across the 2014–2022 seasons
Authors:
Open Access
Abstract
No abstract availableKeywords
Funding Information
- University of Georgia (GRA-001)
- University of California San Diego
- National Institute of Allergy and Infectious Diseases (75N93019C00052)
- National Center for Advancing Translational Sciences
- National Institutes of Health
This publication has 51 references indexed in Scilit:
- Influenza Vaccine Immune Response in Patients With High-Risk Cardiovascular DiseaseJAMA Cardiology, 2024
- Humoral and cellular immune memory to four COVID-19 vaccinesCell, 2022
- Does influenza vaccination attenuate the severity of breakthrough infections? A narrative review and recommendations for further researchVaccine, 2021
- Improving Vaccine-Induced Immunity: Can Baseline Predict Outcome?Trends in Immunology, 2020
- Influenza vaccine effectiveness in preventing influenza-associated intensive care admissions and attenuating severe disease among adults in New Zealand 2012–2015Vaccine, 2018
- Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular SignaturesImmunity, 2015
- Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trialJournal of Gastroenterology, 2015
- Global Analyses of Human Immune Variation Reveal Baseline Predictors of Postvaccination ResponsesCell, 2014
- Early kinetics of antibody response to inactivated influenza vaccineClinical and Diagnostic Virology, 1994
- USE OF ADJUVANTS IN STUDIES ON INFLUENZA IMMUNIZATIONJAMA, 1953